Cargando…

Renin–angiotensin system blocker use and the risk of acute kidney injury after colorectal cancer surgery: a population-based cohort study

OBJECTIVES: It is unknown whether preoperative use of ACE inhibitors (ACE-I) or angiotensin receptor blockers (ARBs) affects the risk of acute kidney injury (AKI) after colorectal cancer (CRC) surgery. We assessed the impact of preoperative ACE-I/ARB use on risk of AKI after CRC surgery. DESIGN: Obs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slagelse, Charlotte, Gammelager, H, Iversen, Lene Hjerrild, Liu, Kathleen D, Sørensen, Henrik T Toft, Christiansen, Christian F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887015/ https://www.ncbi.nlm.nih.gov/pubmed/31753901 http://dx.doi.org/10.1136/bmjopen-2019-032964

Ejemplares similares

Acute kidney injury and 1-year mortality after colorectal cancer surgery: a population-based cohort study
por: Slagelse, Charlotte, et al.
Publicado: (2019)

Renin–Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study
por: Christiansen, Christian Fynbo, et al.
Publicado: (2020)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Expression of the Components of the Renin–Angiotensin System in Venous Malformation
por: Siljee, Sam, et al.
Publicado: (2016)

Expression of Components of the Renin-Angiotensin System in Pyogenic Granuloma
por: Papali'i-Curtin, Jessica C., et al.
Publicado: (2019)

Renin-angiotensin system blockers and COVID-19
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2021)

One-year mortality among Danish intensive care patients with acute kidney injury: a cohort study
por: Gammelager, Henrik, et al.
Publicado: (2012)

Three-year risk of cardiovascular disease among intensive care patients with acute kidney injury: a population-based cohort study
por: Gammelager, Henrik, et al.
Publicado: (2014)

Impact of Renin‐Angiotensin System Blockers on Mortality in Veterans Undergoing Cardiac Surgery
por: Antoniak, Derrick T., et al.
Publicado: (2021)

Five-year risk of end-stage renal disease among intensive care patients surviving dialysis-requiring acute kidney injury: a nationwide cohort study
por: Gammelager, Henrik, et al.
Publicado: (2013)

Glioblastoma Multiforme Cancer Stem Cells Express Components of the Renin–Angiotensin System
por: Bradshaw, Amy Ruth, et al.
Publicado: (2016)

The Role of the Renin-Angiotensin System and Vitamin D in Keloid Disorder—A Review
por: Kilmister, Ethan J., et al.
Publicado: (2019)

Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis
por: Morishita, Yoshiyuki, et al.
Publicado: (2014)

Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney
por: Jiang, Xiao, et al.
Publicado: (2020)

Effect of bariatric surgery on cardiac structure and function in obese patients: Role of the renin‐angiotensin system
por: Oliveras, Anna, et al.
Publicado: (2020)

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
por: Mancia, Giuseppe, et al.
Publicado: (2020)

Insights Into Vascular Anomalies, Cancer, and Fibroproliferative Conditions: The Role of Stem Cells and the Renin-Angiotensin System
por: Kilmister, Ethan J., et al.
Publicado: (2022)

Effect of renin-angiotensin-system blockers on contrast-medium-induced acute kidney injury after coronary angiography
por: Goo, Ja-Jun, et al.
Publicado: (2014)

Prescription of renin–angiotensin system blockers and risk of acute kidney injury: a population-based cohort study
por: Mansfield, Kathryn E, et al.
Publicado: (2016)

Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients
por: Farid fahmy, Sarah, et al.
Publicado: (2023)

Association of Renin-Angiotensin System Blockers With Outcomes in Patients with COVID-19
por: Garg, Aakash, et al.
Publicado: (2020)

Association of Renin-Angiotensin System Blockers with Survival in Patients on Maintenance Hemodialysis
por: Kang, Seok Hui, et al.
Publicado: (2023)

Protection against death and renal failure by renin-angiotensin system blockers in patients with diabetes and kidney disease
por: Shen, Jian, et al.
Publicado: (2016)

Renin-angiotensin-aldosterone system blockers in Bulgarian COVID-19 patients with or without chronic kidney disease
por: Filev, Rumen, et al.
Publicado: (2022)

Angiotensin II Receptor Blocker Attenuates Intrarenal Renin-Angiotensin-System and Podocyte Injury in Rats with Myocardial Infarction
por: Wen, Zhu-zhi, et al.
Publicado: (2013)

Cancer Stem Cells in Moderately Differentiated Lip Squamous Cell Carcinoma Express Components of the Renin–Angiotensin System
por: Ram, Rachna S., et al.
Publicado: (2017)

Expression of Components of the Renin-Angiotensin System by the Putative Stem Cell Population Within WHO Grade I Meningioma
por: Shivapathasundram, Ganeshwaran, et al.
Publicado: (2019)

Cancer Stem Cells in Moderately Differentiated Buccal Mucosal Squamous Cell Carcinoma Express Components of the Renin–Angiotensin System
por: Featherston, Therese, et al.
Publicado: (2016)

The renin-angiotensin system and aging in the kidney
por: Yoon, Hye Eun, et al.
Publicado: (2014)

Renin–angiotensin system blockers during the COVID-19 pandemic: an update for patients with hypertension and chronic kidney disease
por: Theodorakopoulou, Marieta P, et al.
Publicado: (2021)

The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis
por: Harel, Ziv, et al.
Publicado: (2012)

A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors
por: Siragy, Helmy M
Publicado: (2011)

Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin‐angiotensin blockers
por: Heerspink, H. J. L., et al.
Publicado: (2016)

Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro
por: Caminhotto, R de O., et al.
Publicado: (2016)

Renin-angiotensin system blockers and severe acute respiratory syndrome coronavirus 2
por: Lévy, Bernard I., et al.
Publicado: (2020)

In reply— Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Impact of renin-angiotensin system inhibitors and beta-blockers on dental implant stability
por: Saravi, Babak, et al.
Publicado: (2021)

Effect of renin-angiotensin system blocker on COVID-19 in young patients with hypertension
por: Kuzeytemiz, Mustafa, et al.
Publicado: (2022)

Genetic Variant of the Renin-Angiotensin System and Diabetes Influences Blood Pressure Response to Angiotensin Receptor Blockers
por: Konoshita, Tadashi, et al.
Publicado: (2009)

Fixed-Dose Combinations of Renin–Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors
por: Hsiao, Fu-Chih, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8mctmfpduf0h5r31t3imf7vkbk